RepliCel Life Sciences

RepliCel Life Sciences

RepliCel Life Sciences engages in developing hair follicle cell replication technology for patients suffering from androgenetic alopecia. Learn more

Launch date
Employees
Market cap
CAD3.6m
Enterprise valuation
CAD4m (Public information from Jul 2024)
North Vancouver British Columbia (HQ)
Authorizing premium user...